These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 31692885)

  • 61. Direct inhibition of c-Jun N-terminal kinase in sympathetic neurones prevents c-jun promoter activation and NGF withdrawal-induced death.
    Eilers A; Whitfield J; Shah B; Spadoni C; Desmond H; Ham J
    J Neurochem; 2001 Mar; 76(5):1439-54. PubMed ID: 11238729
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Correction: The attenuated hepatocellular carcinoma-specific Listeria vaccine Lmdd-MPFG prevents tumor occurrence through immune regulation of dendritic cells.
    Wan X; Cheng C; Lin Z; Jiang R; Zhao W; Yan X; Tang J; Yao K; Sun B; Chen Y
    Oncotarget; 2022; 13():271-272. PubMed ID: 35111282
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Correction: Bushen-Yizhi formula ameliorates cognitive dysfunction through SIRT1/ER stress pathway in SAMP8 mice.
    Zhang SJ; Xu TT; Li L; Xu YM; Qu ZL; Wang XC; Huang SQ; Luo Y; Luo NC; Lu P; Shi YF; Yang X; Wang Q
    Oncotarget; 2020 Jul; 11(27):2684-2685. PubMed ID: 32676169
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Correction: Identification of neoepitopes recognized by tumor-infiltrating lymphocytes (TILs) from patients with glioma.
    Valentini D; Rao M; Meng Q; von Landenberg A; Bartek J; Sinclair G; Paraschoudi G; Jäger E; Harvey-Peredo I; Dodoo E; Maeurer M
    Oncotarget; 2018 Dec; 9(95):36817. PubMed ID: 30613370
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Correction: Loss of
    Wei Y; Li K; Yao S; Gao J; Li J; Shang Y; Zhang J; Zhang L; Li Y; Mo X; Meng W; Xiang R; Hu J; Lin P; Wei Y
    Oncotarget; 2019 Dec; 10(67):7179-7180. PubMed ID: 31903174
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Correction: Down-regulation of G9a triggers DNA damage response and inhibits colorectal cancer cells proliferation.
    Zhang J; He P; Xi Y; Geng M; Chen Y; Ding J
    Oncotarget; 2020 Jan; 11(3):302-303. PubMed ID: 32076491
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Correction: ABL kinase inhibition sensitizes primary lung adenocarcinomas to chemotherapy by promoting tumor cell differentiation.
    Khatri A; Gu JJ; McKernan CM; Xu X; Pendergast AM
    Oncotarget; 2019 Oct; 10(57):6045-6046. PubMed ID: 31666936
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Correction: P-cadherin mutations are associated with high basal Wnt activity and stemness in canine mammary tumor cell lines.
    Timmermans-Sprang E; Collin RWJ; Henkes A; Philipsen M; Mol JA
    Oncotarget; 2020 Feb; 11(5):573. PubMed ID: 32082491
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Correction: Cycling hypoxia affects cell invasion and proliferation through direct regulation of claudin1 / claudin7 expression, and indirect regulation of p18 through claudin7.
    Liu H; Jiang F; Jia X; Lan J; Guo H; Li E; Yan A; Wang Y
    Oncotarget; 2021 Sep; 12(19):1966-1969. PubMed ID: 34548914
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Correction: A new bioluminescent reporter system to study the biodistribution of systematically injected tumor-derived bioluminescent extracellular vesicles in mice.
    Gangadaran P; Li XJ; Lee HW; Oh JM; Kalimuthu S; Rajendran RL; Son SH; Baek SH; Singh TD; Zhu L; Jeong SY; Lee SW; Lee J; Ahn BC
    Oncotarget; 2020 Mar; 11(11):1004-1005. PubMed ID: 32215188
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Correction: The benefit of tumor molecular profiling on predicting treatments for colorectal adenocarcinomas.
    Carter P; Alifrangis C; Chandrasinghe P; Cereser B; Del Bel Belluz L; Leo CA; Moderau N; Tabassum N; Warusavitarne J; Krell J; Stebbing J
    Oncotarget; 2018 Mar; 9(19):15165. PubMed ID: 29601069
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Correction: Assessing tumor molecular profiling to guide treatments for patients with advanced female genital tract malignancy.
    Carter P; Alifrangis C; Cereser B; Chandrasinghe P; Del Bel Belluz L; Fotopoulou C; Frilling A; Herzog T; Moderau N; Tabassum N; Krell J; Stebbing J
    Oncotarget; 2018 Mar; 9(19):15164. PubMed ID: 29601055
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The Role of Cytoskeleton Protein 4.1 in Immunotherapy.
    Si C; Yuan L; Chen C; Wang T; Kang Q
    Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835189
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Correction: Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cells.
    Yu X; Ai J; Cai L; Jing Y; Wang D; Dong J; Pascal LE; Zhang J; Luo R; Wang Z
    Oncotarget; 2019 Dec; 10(67):7181-7182. PubMed ID: 31903175
    [TBL] [Abstract][Full Text] [Related]  

  • 75. 4.1N is involved in a flotillin-1/β-catenin/Wnt pathway and suppresses cell proliferation and migration in non-small cell lung cancer cell lines.
    Yang Q; Zhu M; Wang Z; Li H; Zhou W; Xiao X; Zhang B; Hu W; Liu J
    Tumour Biol; 2016 Sep; 37(9):12713-12723. PubMed ID: 27448302
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Correction: CAPN1 is a novel binding partner and regulator of the tumor suppressor NF1 in melanoma.
    Alon M; Arafeh R; Lee JS; Madan S; Kalaora S; Nagler A; Abgarian T; Greenberg P; Ruppin E; Samuels Y
    Oncotarget; 2019 Feb; 10(13):1344. PubMed ID: 30863494
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Correction: Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
    Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
    Oncotarget; 2019 Oct; 10(58):6285. PubMed ID: 31692885
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.
    Wang Z; Ma B; Li H; Xiao X; Zhou W; Liu F; Zhang B; Zhu M; Yang Q; Zeng Y; Sun Y; Sun S; Wang Y; Zhang Y; Weng H; Chen L; Ye M; An X; Liu J
    Oncotarget; 2016 Jan; 7(1):509-23. PubMed ID: 26575790
    [TBL] [Abstract][Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.